Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment

FECM Peeters, SJR Meex, MR Dweck… - European heart …, 2018 - academic.oup.com
Calcific aortic valve stenosis (CAVS) is common in the ageing population and set to become
an increasing economic and health burden. Once present, it inevitably progresses and has a …

Molecular mechanisms of bone 18F-NaF deposition

J Czernin, N Satyamurthy… - Journal of Nuclear …, 2010 - Soc Nuclear Med
There is renewed interest in 18F-NaF bone imaging with PET or PET/CT. The current brief
discussion focuses on the molecular mechanisms of 18F-NaF deposition in bone and …

Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology

MR Dweck, MWL Chow, NV Joshi, MC Williams… - Journal of the American …, 2012 - jacc.org
Objectives: With combined positron emission tomography and computed tomography (CT),
we investigated coronary arterial uptake of 18F-sodium fluoride (18F-NaF) and 18F …

SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0

G Segall, D Delbeke, MG Stabin… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The Society of Nuclear Medicine (SNM) is an international scientific and professional
organization founded in 1954 to promote the science, technology, and practical application …

Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis

MR Dweck, C Jones, NV Joshi, AM Fletcher… - Circulation, 2012 - Am Heart Assoc
Background—The pathophysiology of aortic stenosis is incompletely understood, and the
relative contributions of valvular calcification and inflammation to disease progression are …

[HTML][HTML] Garetosmab in fibrodysplasia ossificans progressiva: A randomized, double-blind, placebo-controlled phase 2 trial

M Di Rocco, E Forleo-Neto, RJ Pignolo, R Keen… - Nature medicine, 2023 - nature.com
Fibrodysplasia ossificans progressiva (FOP) is a rare disease characterized by heterotopic
ossification (HO) in connective tissues and painful flare-ups. In the phase 2 LUMINA-1 trial …

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …

SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

Sulfur [18F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis

Q Zheng, H Xu, H Wang, WGH Du… - Journal of the …, 2021 - ACS Publications
The lack of efficient [18F] fluorination processes and target-specific organofluorine
chemotypes remains the major challenge of fluorine-18 positron emission tomography …

18F-Fluoride Signal Amplification Identifies Microcalcifications Associated With Atherosclerotic Plaque Instability in Positron Emission Tomography/Computed …

MD Creager, T Hohl, JD Hutcheson… - Circulation …, 2019 - Am Heart Assoc
Background: Microcalcifications in atherosclerotic plaques are destabilizing, predict adverse
cardiovascular events, and are associated with increased morbidity and mortality. 18F …

Newer PET Application with an Old Tracer: Role of 18F-NaF Skeletal PET/CT in Oncologic Practice

S Bastawrous, P Bhargava, F Behnia, DSW Djang… - Radiographics, 2014 - pubs.rsna.org
The skeleton is one of the most common sites for metastatic disease, particularly from breast
and prostate cancer. Bone metastases are associated with considerable morbidity, and …